Lucid Diagnostics (LUCD) Other Non Operating Income (2021 - 2025)
Lucid Diagnostics (LUCD) posted Other Non Operating Income of $6.1 million for Q4 2025, up 348.97% on a QoQ basis from $1.4 million in Q3 2025, and up 225.93% year-over-year from $1.9 million in Q4 2024.
Lucid Diagnostics (LUCD) Other Non Operating Income (2021 - 2025) Analysis & Trends
Lucid Diagnostics' Other Non Operating Income history runs 5 years deep, the most recent figure standing at $6.1 million for Q4 2025.
- Quarterly Other Non Operating Income rose 225.93% year-over-year to $6.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1000.0 (up 100.02% YoY) and the FY2024 annual result came in at -$5.2 million, down 19773.08% from the prior year.
- Other Non Operating Income was $6.1 million for Q4 2025 at Lucid Diagnostics, up from $1.4 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $6.9 million in Q2 2025 and bottomed at -$14.4 million in Q1 2025.
- A 5-year average of -$303684.2 and a median of $4000.0 in 2022 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 10072.34% in 2023, while the deepest fall reached 193100.0% in 2023.
- Lucid Diagnostics' Other Non Operating Income stood at -$65000.0 in 2021, then surged by 172.31% to $47000.0 in 2022, then jumped by 10072.34% to $4.8 million in 2023, then sank by 201.57% to -$4.9 million in 2024, then surged by 225.93% to $6.1 million in 2025.
- Business Quant data shows LUCD's Other Non Operating Income at $6.1 million in Q4 2025, $1.4 million in Q3 2025, and $6.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.12 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 6.95 Mn |
| Mar 31, 2025 | -14.42 Mn |
| Dec 31, 2024 | -4.86 Mn |
| Sep 30, 2024 | -677,000.00 |
| Jun 30, 2024 | 187,000.00 |
| Mar 31, 2024 | 180,000.00 |
| Dec 31, 2023 | 4.78 Mn |
| Sep 30, 2023 | -3.08 Mn |
| Jun 30, 2023 | 203,000.00 |
| Mar 31, 2023 | -1.93 Mn |
| Dec 31, 2022 | 47,000.00 |
| Sep 30, 2022 | 28,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | -65,000.00 |
| Sep 30, 2021 | -447,000.00 |
| Jun 30, 2021 | -147,000.00 |